Share Price and Basic Stock Data
Last Updated: December 9, 2025, 9:55 pm
| PEG Ratio | -1.34 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
UPL Ltd, a major player in the agrochemicals sector, has shown a compelling revenue trajectory over the years. As of March 2023, the company reported sales of ₹53,576 Cr, a notable increase from ₹46,240 Cr in the previous year. However, the subsequent fiscal year (FY 2024) saw a decline to ₹43,098 Cr, indicating some volatility in performance. The latest quarterly figures indicate a mixed bag, with Q1 FY 2025 recording sales of ₹14,078 Cr, which suggests a bounce-back from the previous quarter, where sales dipped to ₹9,887 Cr. This fluctuation could be attributed to seasonal demand patterns in the agricultural sector and varying market conditions. The company’s ability to navigate these ups and downs will be crucial as it aims to stabilize and grow its revenue streams further.
Profitability and Efficiency Metrics
Profitability metrics for UPL paint a picture of fluctuating margins in recent periods. The operating profit margin (OPM) stood at a healthy 19% for FY 2023 but declined significantly to just 10% in FY 2024. This drop underscores challenges in managing costs amid rising input prices and competitive pressures. The net profit for FY 2024 turned negative, falling to ₹-1,878 Cr, which starkly contrasts with the ₹4,414 Cr reported in FY 2023. Such a significant downturn raises concerns regarding operational efficiency. The interest coverage ratio (ICR) at 2.23x suggests that UPL can meet its interest obligations comfortably, though it’s a decline from previous years, indicating a tightening financial environment. Investors should note that while UPL has historically maintained solid profitability, the recent trends warrant cautious observation.
Balance Sheet Strength and Financial Ratios
UPL’s balance sheet reflects a complex scenario, with total borrowings amounting to ₹30,022 Cr, which is quite substantial compared to reserves of ₹31,725 Cr as of September 2025. The debt-to-equity ratio stands at 0.81x, suggesting a moderate leverage position that could be manageable but not without its risks. The current ratio of 1.39x indicates a comfortable liquidity position, allowing the company to cover its short-term liabilities. However, the return on equity (ROE) at just 3.29% and return on capital employed (ROCE) at 7.66% appear weak compared to industry benchmarks, raising questions about how effectively the company is utilizing its capital. This balance sheet strength, while solid on the surface, reveals potential weaknesses that investors must consider, particularly in an environment where efficient capital deployment is critical.
Shareholding Pattern and Investor Confidence
The shareholding structure of UPL Ltd indicates a diverse base of institutional and retail investors, with foreign institutional investors (FIIs) holding 37.01% and domestic institutional investors (DIIs) at 17.17%. This mixture suggests a level of confidence in UPL’s long-term prospects, particularly as FIIs have gradually increased their stake over recent quarters. Promoter holdings have remained stable at around 33.49%, which can signal stability and commitment to the company’s future. However, the public shareholding has decreased to 12.33%, which could indicate a potential lack of retail enthusiasm amid recent performance challenges. Overall, while institutional support appears strong, the declining public interest raises questions about broader investor sentiment and the company’s ability to attract retail participation moving forward.
Outlook, Risks, and Final Insight
The outlook for UPL Ltd hinges on several critical factors, including global agricultural trends, input cost management, and operational efficiency. While the company’s strong institutional backing provides a buffer, the recent dips in profitability and sales suggest that operational challenges need addressing. The agrochemical market is inherently cyclical, and UPL must navigate these cycles adeptly to sustain growth. Risks such as fluctuating commodity prices, regulatory changes, and competition from both domestic and international players could further impact performance. Investors should consider these dynamics carefully. The current valuation metrics, including a P/E of 27.0 and P/BV of 1.73x, indicate that the stock is not necessarily undervalued, especially given the recent performance. Thus, while UPL offers a portfolio diversification opportunity in the agrochemicals space, potential investors should proceed with caution, keeping a close eye on operational improvements and market conditions.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of UPL Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Epigral Ltd | 6,219 Cr. | 1,445 | 2,196/1,398 | 15.5 | 487 | 0.42 % | 24.9 % | 22.3 % | 10.0 |
| Dharmaj Crop Guard Ltd | 828 Cr. | 244 | 391/165 | 17.0 | 131 | 0.00 % | 12.0 % | 9.28 % | 10.0 |
| Bhaskar Agrochemicals Ltd | 66.6 Cr. | 128 | 149/56.6 | 11.9 | 40.0 | 0.00 % | 21.3 % | 24.7 % | 10.0 |
| Bhagiradha Chemicals & Industries Ltd | 3,079 Cr. | 236 | 349/226 | 116 | 54.9 | 0.06 % | 7.44 % | 4.91 % | 1.00 |
| Best Agrolife Ltd | 881 Cr. | 373 | 670/244 | 68.8 | 342 | 0.80 % | 12.9 % | 9.95 % | 10.0 |
| Industry Average | 10,960.00 Cr | 1,450.75 | 32.20 | 472.46 | 0.44% | 15.21% | 19.87% | 7.25 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 10,821 | 12,507 | 13,679 | 16,569 | 8,963 | 10,170 | 9,887 | 14,078 | 9,067 | 11,090 | 10,907 | 15,573 | 9,216 |
| Expenses | 8,675 | 10,090 | 10,795 | 13,847 | 7,747 | 9,049 | 9,820 | 12,230 | 7,998 | 9,873 | 9,229 | 12,409 | 7,820 |
| Operating Profit | 2,146 | 2,417 | 2,884 | 2,722 | 1,216 | 1,121 | 67 | 1,848 | 1,069 | 1,217 | 1,678 | 3,164 | 1,396 |
| OPM % | 20% | 19% | 21% | 16% | 14% | 11% | 1% | 13% | 12% | 11% | 15% | 20% | 15% |
| Other Income | 25 | 35 | 129 | 302 | 58 | 18 | 134 | 66 | 49 | 103 | 94 | -168 | 152 |
| Interest | 519 | 644 | 894 | 906 | 700 | 871 | 1,191 | 1,090 | 913 | 1,070 | 730 | 914 | 1,007 |
| Depreciation | 588 | 608 | 624 | 727 | 636 | 657 | 676 | 794 | 660 | 697 | 688 | 705 | 731 |
| Profit before tax | 1,064 | 1,200 | 1,495 | 1,391 | -62 | -389 | -1,666 | 30 | -455 | -447 | 354 | 1,377 | -190 |
| Tax % | 6% | 19% | 9% | 22% | -265% | -25% | -4% | 367% | 16% | 31% | -141% | 22% | -7% |
| Net Profit | 1,005 | 969 | 1,360 | 1,080 | 102 | -293 | -1,607 | -80 | -527 | -585 | 853 | 1,079 | -176 |
| EPS in Rs | 10.39 | 9.64 | 12.87 | 9.38 | 1.97 | -2.24 | -14.41 | 0.47 | -4.55 | -5.25 | 9.81 | 10.61 | -1.04 |
Last Updated: August 20, 2025, 1:45 am
Below is a detailed analysis of the quarterly data for UPL Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 9,216.00 Cr.. The value appears to be declining and may need further review. It has decreased from 15,573.00 Cr. (Mar 2025) to 9,216.00 Cr., marking a decrease of 6,357.00 Cr..
- For Expenses, as of Jun 2025, the value is 7,820.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 12,409.00 Cr. (Mar 2025) to 7,820.00 Cr., marking a decrease of 4,589.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 1,396.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3,164.00 Cr. (Mar 2025) to 1,396.00 Cr., marking a decrease of 1,768.00 Cr..
- For OPM %, as of Jun 2025, the value is 15.00%. The value appears to be declining and may need further review. It has decreased from 20.00% (Mar 2025) to 15.00%, marking a decrease of 5.00%.
- For Other Income, as of Jun 2025, the value is 152.00 Cr.. The value appears strong and on an upward trend. It has increased from -168.00 Cr. (Mar 2025) to 152.00 Cr., marking an increase of 320.00 Cr..
- For Interest, as of Jun 2025, the value is 1,007.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 914.00 Cr. (Mar 2025) to 1,007.00 Cr., marking an increase of 93.00 Cr..
- For Depreciation, as of Jun 2025, the value is 731.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 705.00 Cr. (Mar 2025) to 731.00 Cr., marking an increase of 26.00 Cr..
- For Profit before tax, as of Jun 2025, the value is -190.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,377.00 Cr. (Mar 2025) to -190.00 Cr., marking a decrease of 1,567.00 Cr..
- For Tax %, as of Jun 2025, the value is -7.00%. The value appears to be improving (decreasing) as expected. It has decreased from 22.00% (Mar 2025) to -7.00%, marking a decrease of 29.00%.
- For Net Profit, as of Jun 2025, the value is -176.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,079.00 Cr. (Mar 2025) to -176.00 Cr., marking a decrease of 1,255.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is -1.04. The value appears to be declining and may need further review. It has decreased from 10.61 (Mar 2025) to -1.04, marking a decrease of 11.65.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 4:12 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 10,771 | 12,091 | 14,048 | 16,312 | 17,378 | 21,837 | 35,756 | 38,694 | 46,240 | 53,576 | 43,098 | 46,637 | 46,786 |
| Expenses | 8,753 | 9,728 | 11,700 | 13,346 | 13,966 | 18,024 | 28,984 | 30,342 | 36,711 | 43,380 | 38,801 | 39,509 | 39,331 |
| Operating Profit | 2,018 | 2,363 | 2,348 | 2,966 | 3,412 | 3,813 | 6,772 | 8,352 | 9,529 | 10,196 | 4,297 | 7,128 | 7,455 |
| OPM % | 19% | 20% | 17% | 18% | 20% | 17% | 19% | 22% | 21% | 19% | 10% | 15% | 16% |
| Other Income | 30 | -11 | 149 | 363 | 351 | -197 | -515 | 62 | 91 | 464 | 231 | 78 | 181 |
| Interest | 485 | 517 | 704 | 735 | 783 | 963 | 1,481 | 2,060 | 2,295 | 2,963 | 3,852 | 3,627 | 3,721 |
| Depreciation | 407 | 425 | 676 | 672 | 675 | 880 | 2,012 | 2,173 | 2,359 | 2,547 | 2,763 | 2,750 | 2,821 |
| Profit before tax | 1,157 | 1,410 | 1,117 | 1,922 | 2,305 | 1,773 | 2,764 | 4,181 | 4,966 | 5,150 | -2,087 | 829 | 1,094 |
| Tax % | 19% | 17% | 15% | 10% | 12% | 11% | 21% | 16% | 11% | 14% | -10% | 1% | |
| Net Profit | 957 | 1,187 | 952 | 1,733 | 2,030 | 1,575 | 2,178 | 3,495 | 4,437 | 4,414 | -1,878 | 820 | 1,171 |
| EPS in Rs | 13.13 | 15.82 | 13.00 | 20.18 | 23.57 | 17.35 | 20.66 | 33.40 | 42.18 | 42.28 | -14.21 | 10.62 | 14.13 |
| Dividend Payout % | 18% | 19% | 23% | 20% | 20% | 27% | 26% | 27% | 21% | 21% | -6% | 53% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 24.03% | -19.80% | 82.04% | 17.14% | -22.41% | 38.29% | 60.47% | 26.95% | -0.52% | -142.55% | 143.66% |
| Change in YoY Net Profit Growth (%) | 0.00% | -43.83% | 101.84% | -64.90% | -39.55% | 60.70% | 22.18% | -33.52% | -27.47% | -142.03% | 286.21% |
UPL Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 5% |
| 3 Years: | 0% |
| TTM: | 8% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -2% |
| 5 Years: | -16% |
| 3 Years: | -38% |
| TTM: | 182% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 7% |
| 3 Years: | -1% |
| 1 Year: | 17% |
| Return on Equity | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 8% |
| 3 Years: | 4% |
| Last Year: | 3% |
Last Updated: September 5, 2025, 1:50 pm
Balance Sheet
Last Updated: December 4, 2025, 2:10 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 86 | 86 | 86 | 101 | 102 | 102 | 153 | 153 | 153 | 150 | 150 | 159 | 169 |
| Reserves | 5,162 | 5,775 | 5,803 | 7,214 | 9,067 | 14,613 | 19,129 | 20,734 | 24,508 | 26,708 | 24,657 | 29,054 | 31,725 |
| Borrowings | 3,349 | 3,281 | 5,258 | 6,443 | 6,638 | 29,139 | 29,388 | 24,519 | 26,746 | 23,939 | 29,754 | 25,099 | 30,022 |
| Other Liabilities | 4,162 | 5,143 | 5,722 | 6,454 | 7,148 | 18,581 | 19,758 | 23,359 | 29,196 | 35,318 | 30,579 | 31,700 | 29,475 |
| Total Liabilities | 12,759 | 14,284 | 16,869 | 20,212 | 22,955 | 62,435 | 68,428 | 68,765 | 80,603 | 86,115 | 85,140 | 86,012 | 91,391 |
| Fixed Assets | 3,821 | 4,031 | 3,862 | 4,071 | 4,437 | 32,149 | 35,321 | 34,765 | 36,193 | 38,713 | 39,056 | 39,084 | 42,247 |
| CWIP | 228 | 583 | 484 | 792 | 1,319 | 1,855 | 2,073 | 2,117 | 2,501 | 2,818 | 2,965 | 2,546 | 794 |
| Investments | 737 | 764 | 335 | 378 | 1,034 | 708 | 558 | 618 | 1,922 | 1,615 | 2,154 | 2,328 | 2,604 |
| Other Assets | 7,973 | 8,906 | 12,188 | 14,971 | 16,165 | 27,723 | 30,476 | 31,265 | 39,987 | 42,969 | 40,965 | 42,054 | 45,746 |
| Total Assets | 12,759 | 14,284 | 16,869 | 20,212 | 22,955 | 62,435 | 68,428 | 68,765 | 80,603 | 86,115 | 85,140 | 86,012 | 91,391 |
Below is a detailed analysis of the balance sheet data for UPL Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 169.00 Cr.. The value appears strong and on an upward trend. It has increased from 159.00 Cr. (Mar 2025) to 169.00 Cr., marking an increase of 10.00 Cr..
- For Reserves, as of Sep 2025, the value is 31,725.00 Cr.. The value appears strong and on an upward trend. It has increased from 29,054.00 Cr. (Mar 2025) to 31,725.00 Cr., marking an increase of 2,671.00 Cr..
- For Borrowings, as of Sep 2025, the value is 30,022.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 25,099.00 Cr. (Mar 2025) to 30,022.00 Cr., marking an increase of 4,923.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 29,475.00 Cr.. The value appears to be improving (decreasing). It has decreased from 31,700.00 Cr. (Mar 2025) to 29,475.00 Cr., marking a decrease of 2,225.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 91,391.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 86,012.00 Cr. (Mar 2025) to 91,391.00 Cr., marking an increase of 5,379.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 42,247.00 Cr.. The value appears strong and on an upward trend. It has increased from 39,084.00 Cr. (Mar 2025) to 42,247.00 Cr., marking an increase of 3,163.00 Cr..
- For CWIP, as of Sep 2025, the value is 794.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,546.00 Cr. (Mar 2025) to 794.00 Cr., marking a decrease of 1,752.00 Cr..
- For Investments, as of Sep 2025, the value is 2,604.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,328.00 Cr. (Mar 2025) to 2,604.00 Cr., marking an increase of 276.00 Cr..
- For Other Assets, as of Sep 2025, the value is 45,746.00 Cr.. The value appears strong and on an upward trend. It has increased from 42,054.00 Cr. (Mar 2025) to 45,746.00 Cr., marking an increase of 3,692.00 Cr..
- For Total Assets, as of Sep 2025, the value is 91,391.00 Cr.. The value appears strong and on an upward trend. It has increased from 86,012.00 Cr. (Mar 2025) to 91,391.00 Cr., marking an increase of 5,379.00 Cr..
Notably, the Reserves (31,725.00 Cr.) exceed the Borrowings (30,022.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -1.00 | -1.00 | -3.00 | -4.00 | -3.00 | -26.00 | -23.00 | -16.00 | -17.00 | -13.00 | -25.00 | -18.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 109 | 115 | 133 | 127 | 127 | 195 | 121 | 115 | 121 | 124 | 138 | 121 |
| Inventory Days | 166 | 178 | 204 | 194 | 204 | 306 | 153 | 180 | 216 | 187 | 198 | 167 |
| Days Payable | 181 | 195 | 213 | 228 | 255 | 330 | 199 | 244 | 274 | 236 | 196 | 176 |
| Cash Conversion Cycle | 95 | 98 | 124 | 93 | 76 | 171 | 75 | 51 | 64 | 76 | 141 | 112 |
| Working Capital Days | 64 | 45 | 48 | 84 | 94 | 127 | 59 | 52 | 38 | 46 | 52 | 9 |
| ROCE % | 19% | 21% | 19% | 22% | 21% | 10% | 10% | 13% | 14% | 14% | 3% | 8% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| ICICI Prudential Multi Asset Fund | 5,665,825 | 0.57 | 408 | N/A | N/A | N/A |
| ICICI Prudential Large & Mid Cap Fund | 4,727,999 | 1.32 | 340.46 | N/A | N/A | N/A |
| ICICI Prudential MidCap Fund | 3,465,469 | 3.58 | 249.55 | N/A | N/A | N/A |
| ICICI Prudential India Opportunities Fund | 3,155,047 | 0.7 | 227.19 | N/A | N/A | N/A |
| ICICI Prudential Multicap Fund | 2,807,724 | 1.26 | 202.18 | N/A | N/A | N/A |
| Mirae Asset Midcap Fund | 2,477,280 | 0.98 | 178.39 | N/A | N/A | N/A |
| Franklin India Mid Cap Fund | 2,425,000 | 1.37 | 174.62 | N/A | N/A | N/A |
| ICICI Prudential Commodities Fund | 2,093,346 | 4.73 | 150.74 | N/A | N/A | N/A |
| Tata Mid Cap Fund | 1,700,000 | 2.32 | 122.42 | N/A | N/A | N/A |
| Franklin India Opportunities Fund | 1,445,260 | 1.27 | 104.07 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Basic EPS (Rs.) | 9.85 | -17.80 | 45.79 | 45.87 | 36.40 |
| Diluted EPS (Rs.) | 9.62 | -17.80 | 45.79 | 45.87 | 36.40 |
| Cash EPS (Rs.) | 50.84 | 15.03 | 90.72 | 87.08 | 73.54 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 367.46 | 330.76 | 432.57 | 344.08 | 282.27 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 367.46 | 330.76 | 432.57 | 344.08 | 282.27 |
| Revenue From Operations / Share (Rs.) | 586.63 | 574.64 | 714.35 | 604.44 | 505.80 |
| PBDIT / Share (Rs.) | 101.71 | 66.96 | 142.31 | 128.24 | 112.55 |
| PBIT / Share (Rs.) | 67.12 | 30.12 | 108.35 | 97.40 | 84.14 |
| PBT / Share (Rs.) | 16.36 | -24.60 | 66.57 | 63.16 | 54.10 |
| Net Profit / Share (Rs.) | 16.25 | -21.81 | 56.76 | 56.25 | 45.14 |
| NP After MI And SOA / Share (Rs.) | 11.28 | -16.00 | 47.60 | 47.40 | 37.53 |
| PBDIT Margin (%) | 17.33 | 11.65 | 19.92 | 21.21 | 22.25 |
| PBIT Margin (%) | 11.44 | 5.24 | 15.16 | 16.11 | 16.63 |
| PBT Margin (%) | 2.78 | -4.28 | 9.31 | 10.44 | 10.69 |
| Net Profit Margin (%) | 2.77 | -3.79 | 7.94 | 9.30 | 8.92 |
| NP After MI And SOA Margin (%) | 1.92 | -2.78 | 6.66 | 7.84 | 7.41 |
| Return on Networth / Equity (%) | 3.07 | -4.83 | 13.29 | 16.72 | 16.03 |
| Return on Capital Employeed (%) | 8.97 | 3.72 | 13.64 | 13.67 | 12.67 |
| Return On Assets (%) | 1.01 | -1.37 | 4.03 | 4.38 | 4.07 |
| Long Term Debt / Equity (X) | 0.62 | 0.96 | 0.75 | 0.99 | 1.24 |
| Total Debt / Equity (X) | 0.81 | 1.15 | 0.85 | 1.19 | 1.32 |
| Asset Turnover Ratio (%) | 0.53 | 0.48 | 0.37 | 0.36 | 0.26 |
| Current Ratio (X) | 1.39 | 1.46 | 1.45 | 1.41 | 1.53 |
| Quick Ratio (X) | 1.03 | 0.98 | 0.96 | 0.94 | 1.05 |
| Inventory Turnover Ratio (X) | 1.58 | 1.43 | 1.45 | 1.41 | 1.15 |
| Dividend Payout Ratio (NP) (%) | 8.36 | -62.41 | 21.03 | 21.07 | 15.95 |
| Dividend Payout Ratio (CP) (%) | 2.05 | 47.92 | 12.27 | 12.76 | 9.08 |
| Earning Retention Ratio (%) | 91.64 | 162.41 | 78.97 | 78.93 | 84.05 |
| Cash Earning Retention Ratio (%) | 97.95 | 52.08 | 87.73 | 87.24 | 90.92 |
| Interest Coverage Ratio (X) | 2.23 | 1.30 | 3.60 | 4.27 | 4.18 |
| Interest Coverage Ratio (Post Tax) (X) | 1.47 | 0.64 | 2.49 | 3.02 | 2.79 |
| Enterprise Value (Cr.) | 70381.90 | 61503.75 | 76295.75 | 83275.05 | 71528.30 |
| EV / Net Operating Revenue (X) | 1.51 | 1.43 | 1.42 | 1.80 | 1.85 |
| EV / EBITDA (X) | 8.70 | 12.25 | 7.15 | 8.49 | 8.31 |
| MarketCap / Net Operating Revenue (X) | 1.08 | 0.79 | 1.00 | 1.27 | 1.27 |
| Retention Ratios (%) | 91.63 | 162.41 | 78.96 | 78.92 | 84.04 |
| Price / BV (X) | 1.73 | 1.38 | 2.00 | 2.72 | 2.74 |
| Price / Net Operating Revenue (X) | 1.08 | 0.79 | 1.00 | 1.27 | 1.27 |
| EarningsYield | 0.01 | -0.03 | 0.06 | 0.06 | 0.05 |
After reviewing the key financial ratios for UPL Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 9.85. This value is within the healthy range. It has increased from -17.80 (Mar 24) to 9.85, marking an increase of 27.65.
- For Diluted EPS (Rs.), as of Mar 25, the value is 9.62. This value is within the healthy range. It has increased from -17.80 (Mar 24) to 9.62, marking an increase of 27.42.
- For Cash EPS (Rs.), as of Mar 25, the value is 50.84. This value is within the healthy range. It has increased from 15.03 (Mar 24) to 50.84, marking an increase of 35.81.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 367.46. It has increased from 330.76 (Mar 24) to 367.46, marking an increase of 36.70.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 367.46. It has increased from 330.76 (Mar 24) to 367.46, marking an increase of 36.70.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 586.63. It has increased from 574.64 (Mar 24) to 586.63, marking an increase of 11.99.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 101.71. This value is within the healthy range. It has increased from 66.96 (Mar 24) to 101.71, marking an increase of 34.75.
- For PBIT / Share (Rs.), as of Mar 25, the value is 67.12. This value is within the healthy range. It has increased from 30.12 (Mar 24) to 67.12, marking an increase of 37.00.
- For PBT / Share (Rs.), as of Mar 25, the value is 16.36. This value is within the healthy range. It has increased from -24.60 (Mar 24) to 16.36, marking an increase of 40.96.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 16.25. This value is within the healthy range. It has increased from -21.81 (Mar 24) to 16.25, marking an increase of 38.06.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 11.28. This value is within the healthy range. It has increased from -16.00 (Mar 24) to 11.28, marking an increase of 27.28.
- For PBDIT Margin (%), as of Mar 25, the value is 17.33. This value is within the healthy range. It has increased from 11.65 (Mar 24) to 17.33, marking an increase of 5.68.
- For PBIT Margin (%), as of Mar 25, the value is 11.44. This value is within the healthy range. It has increased from 5.24 (Mar 24) to 11.44, marking an increase of 6.20.
- For PBT Margin (%), as of Mar 25, the value is 2.78. This value is below the healthy minimum of 10. It has increased from -4.28 (Mar 24) to 2.78, marking an increase of 7.06.
- For Net Profit Margin (%), as of Mar 25, the value is 2.77. This value is below the healthy minimum of 5. It has increased from -3.79 (Mar 24) to 2.77, marking an increase of 6.56.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 1.92. This value is below the healthy minimum of 8. It has increased from -2.78 (Mar 24) to 1.92, marking an increase of 4.70.
- For Return on Networth / Equity (%), as of Mar 25, the value is 3.07. This value is below the healthy minimum of 15. It has increased from -4.83 (Mar 24) to 3.07, marking an increase of 7.90.
- For Return on Capital Employeed (%), as of Mar 25, the value is 8.97. This value is below the healthy minimum of 10. It has increased from 3.72 (Mar 24) to 8.97, marking an increase of 5.25.
- For Return On Assets (%), as of Mar 25, the value is 1.01. This value is below the healthy minimum of 5. It has increased from -1.37 (Mar 24) to 1.01, marking an increase of 2.38.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.62. This value is within the healthy range. It has decreased from 0.96 (Mar 24) to 0.62, marking a decrease of 0.34.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.81. This value is within the healthy range. It has decreased from 1.15 (Mar 24) to 0.81, marking a decrease of 0.34.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.53. It has increased from 0.48 (Mar 24) to 0.53, marking an increase of 0.05.
- For Current Ratio (X), as of Mar 25, the value is 1.39. This value is below the healthy minimum of 1.5. It has decreased from 1.46 (Mar 24) to 1.39, marking a decrease of 0.07.
- For Quick Ratio (X), as of Mar 25, the value is 1.03. This value is within the healthy range. It has increased from 0.98 (Mar 24) to 1.03, marking an increase of 0.05.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 1.58. This value is below the healthy minimum of 4. It has increased from 1.43 (Mar 24) to 1.58, marking an increase of 0.15.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 8.36. This value is below the healthy minimum of 20. It has increased from -62.41 (Mar 24) to 8.36, marking an increase of 70.77.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 2.05. This value is below the healthy minimum of 20. It has decreased from 47.92 (Mar 24) to 2.05, marking a decrease of 45.87.
- For Earning Retention Ratio (%), as of Mar 25, the value is 91.64. This value exceeds the healthy maximum of 70. It has decreased from 162.41 (Mar 24) to 91.64, marking a decrease of 70.77.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 97.95. This value exceeds the healthy maximum of 70. It has increased from 52.08 (Mar 24) to 97.95, marking an increase of 45.87.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 2.23. This value is below the healthy minimum of 3. It has increased from 1.30 (Mar 24) to 2.23, marking an increase of 0.93.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.47. This value is below the healthy minimum of 3. It has increased from 0.64 (Mar 24) to 1.47, marking an increase of 0.83.
- For Enterprise Value (Cr.), as of Mar 25, the value is 70,381.90. It has increased from 61,503.75 (Mar 24) to 70,381.90, marking an increase of 8,878.15.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.51. This value is within the healthy range. It has increased from 1.43 (Mar 24) to 1.51, marking an increase of 0.08.
- For EV / EBITDA (X), as of Mar 25, the value is 8.70. This value is within the healthy range. It has decreased from 12.25 (Mar 24) to 8.70, marking a decrease of 3.55.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.08. This value is within the healthy range. It has increased from 0.79 (Mar 24) to 1.08, marking an increase of 0.29.
- For Retention Ratios (%), as of Mar 25, the value is 91.63. This value exceeds the healthy maximum of 70. It has decreased from 162.41 (Mar 24) to 91.63, marking a decrease of 70.78.
- For Price / BV (X), as of Mar 25, the value is 1.73. This value is within the healthy range. It has increased from 1.38 (Mar 24) to 1.73, marking an increase of 0.35.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.08. This value is within the healthy range. It has increased from 0.79 (Mar 24) to 1.08, marking an increase of 0.29.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. It has increased from -0.03 (Mar 24) to 0.01, marking an increase of 0.04.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in UPL Ltd:
- Net Profit Margin: 2.77%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 8.97% (Industry Average ROCE: 15.21%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 3.07% (Industry Average ROE: 19.87%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.47
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.03
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 26.3 (Industry average Stock P/E: 32.2)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.81
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 2.77%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Agro Chemicals/Pesticides | 3-11, G.I.D.C., Vapi, Valsad District Gujarat 396195 | upl.investors@upl-ltd.com http://www.upl-ltd.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Rajnikant D Shroff | Chairman Emeritus |
| Mr. Jaidev R Shroff | Chairman & Group CEO |
| Mr. Vikram R Shroff | Vice Chairman |
| Mr. Raj Tiwari | Whole Time Director |
| Mr. Hardeep Singh | Non Executive Director |
| Mr. S K Mohanty | Independent Director |
| Dr. Vasant Gandhi | Independent Director |
| Ms. Naina Lal Kidwai | Independent Director |
| Mr. Suresh Kumar | Lead Independent Director |
| Ms. Usha Monari | Independent Director |
| Ms. M V Bhanumathi | Independent Director |
FAQ
What is the intrinsic value of UPL Ltd?
UPL Ltd's intrinsic value (as of 09 December 2025) is 263.78 which is 64.35% lower the current market price of 740.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 62,384 Cr. market cap, FY2025-2026 high/low of 776/493, reserves of ₹31,725 Cr, and liabilities of 91,391 Cr.
What is the Market Cap of UPL Ltd?
The Market Cap of UPL Ltd is 62,384 Cr..
What is the current Stock Price of UPL Ltd as on 09 December 2025?
The current stock price of UPL Ltd as on 09 December 2025 is 740.
What is the High / Low of UPL Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of UPL Ltd stocks is 776/493.
What is the Stock P/E of UPL Ltd?
The Stock P/E of UPL Ltd is 26.3.
What is the Book Value of UPL Ltd?
The Book Value of UPL Ltd is 378.
What is the Dividend Yield of UPL Ltd?
The Dividend Yield of UPL Ltd is 0.81 %.
What is the ROCE of UPL Ltd?
The ROCE of UPL Ltd is 7.66 %.
What is the ROE of UPL Ltd?
The ROE of UPL Ltd is 3.29 %.
What is the Face Value of UPL Ltd?
The Face Value of UPL Ltd is 2.00.